位置:首页 > 蛋白库 > BCAP_CHICK
BCAP_CHICK
ID   BCAP_CHICK              Reviewed;         800 AA.
AC   Q9DDT2; Q9DDL3;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 110.
DE   RecName: Full=Phosphoinositide 3-kinase adapter protein 1;
DE   AltName: Full=B-cell adapter for phosphoinositide 3-kinase;
DE   AltName: Full=B-cell phosphoinositide 3-kinase adapter protein 1;
GN   Name=PIK3AP1; Synonyms=BCAP;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 293-303;
RP   492-505; 560-566; 599-612 AND 614-624, FUNCTION IN B-CELL RECEPTOR
RP   SIGNALING, SUBCELLULAR LOCATION, INTERACTION WITH PIK3R1, PHOSPHORYLATION
RP   AT TYR-266; TYR-423; TYR-448 AND TYR-463, AND MUTAGENESIS OF TYR-266;
RP   TYR-423; TYR-448 AND TYR-463.
RX   PubMed=11163197; DOI=10.1016/s1074-7613(00)00079-0;
RA   Okada T., Maeda A., Iwamatsu A., Gotoh K., Kurosaki T.;
RT   "BCAP: the tyrosine kinase substrate that connects B cell receptor to
RT   phosphoinositide 3-kinase activation.";
RL   Immunity 13:817-827(2000).
RN   [2]
RP   FUNCTION.
RX   PubMed=11781242; DOI=10.1182/blood.v99.2.584;
RA   Inabe K., Kurosaki T.;
RT   "Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase
RT   is required for Akt activation in response to CD19 engagement.";
RL   Blood 99:584-589(2002).
RN   [3]
RP   FUNCTION.
RX   PubMed=12627965; DOI=10.1021/bi0205911;
RA   Qin S., Chock P.B.;
RT   "Implication of phosphatidylinositol 3-kinase membrane recruitment in
RT   hydrogen peroxide-induced activation of PI3K and Akt.";
RL   Biochemistry 42:2995-3003(2003).
CC   -!- FUNCTION: Signaling adapter that contributes to B-cell development by
CC       linking B-cell receptor (BCR) signaling to the phosphoinositide 3-
CC       kinase (PI3K)-Akt signaling pathway. Has a complementary role to the
CC       BCR coreceptor CD19, coupling BCR and PI3K activation by providing a
CC       docking site for the PI3K subunit PIK3R1. Alternatively, links Toll-
CC       like receptor (TLR) signaling to PI3K activation, a process preventing
CC       excessive inflammatory cytokine production. Also involved in the
CC       activation of PI3K in natural killer cells. May be involved in the
CC       survival of mature B-cells via activation of REL.
CC       {ECO:0000269|PubMed:11163197, ECO:0000269|PubMed:11781242,
CC       ECO:0000269|PubMed:12627965}.
CC   -!- SUBUNIT: Homooligomer (By similarity). Interacts (phosphorylated on
CC       tyrosine residues within YXXM motifs) with PIK3R1 (via SH2 domain);
CC       required for BCR- and TLR-mediated activation of phosphoinositide 3-
CC       kinase. {ECO:0000250, ECO:0000269|PubMed:11163197}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11163197}. Cell
CC       membrane {ECO:0000305|PubMed:11163197}; Peripheral membrane protein
CC       {ECO:0000305|PubMed:11163197}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9DDT2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9DDT2-2; Sequence=VSP_034244;
CC   -!- DOMAIN: The DBB domain is required for dimerization. {ECO:0000250}.
CC   -!- PTM: Constitutively phosphorylated (By similarity). Phosphorylated on
CC       tyrosine residues within the YXXM motifs by BTK and SYK. Isoform 1 and
CC       isoform 2 are phosphorylated on tyrosine residues, most likely within
CC       the YXXM motifs, via CD19 activation. {ECO:0000250,
CC       ECO:0000269|PubMed:11163197}.
CC   -!- MISCELLANEOUS: [Isoform 2]: It is unsure whether this isoform is
CC       produced by alternative splicing or alternative initiation.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF293805; AAG48583.1; -; mRNA.
DR   EMBL; AF315784; AAG48619.1; -; mRNA.
DR   RefSeq; NP_989681.1; NM_204350.1. [Q9DDT2-1]
DR   AlphaFoldDB; Q9DDT2; -.
DR   SMR; Q9DDT2; -.
DR   BioGRID; 675276; 1.
DR   STRING; 9031.ENSGALP00000008882; -.
DR   iPTMnet; Q9DDT2; -.
DR   PaxDb; Q9DDT2; -.
DR   Ensembl; ENSGALT00000008896; ENSGALP00000008882; ENSGALG00000005547. [Q9DDT2-1]
DR   Ensembl; ENSGALT00000088192; ENSGALP00000062022; ENSGALG00000005547. [Q9DDT2-2]
DR   GeneID; 374268; -.
DR   KEGG; gga:374268; -.
DR   CTD; 118788; -.
DR   VEuPathDB; HostDB:geneid_374268; -.
DR   eggNOG; ENOG502QS94; Eukaryota.
DR   GeneTree; ENSGT00390000008787; -.
DR   HOGENOM; CLU_012993_0_0_1; -.
DR   InParanoid; Q9DDT2; -.
DR   OMA; IIMKCKL; -.
DR   OrthoDB; 280243at2759; -.
DR   PhylomeDB; Q9DDT2; -.
DR   Reactome; R-GGA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-GGA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-GGA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:Q9DDT2; -.
DR   Proteomes; UP000000539; Chromosome 6.
DR   Bgee; ENSGALG00000005547; Expressed in spleen and 13 other tissues.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0036312; F:phosphatidylinositol 3-kinase regulatory subunit binding; ISS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043549; P:regulation of kinase activity; IMP:BHF-UCL.
DR   GO; GO:0042325; P:regulation of phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0034134; P:toll-like receptor 2 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0034154; P:toll-like receptor 7 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031929; P:TOR signaling; IMP:BHF-UCL.
DR   Gene3D; 3.40.50.10140; -; 1.
DR   InterPro; IPR017893; DBB_domain.
DR   InterPro; IPR041340; PIK3AP1_TIR.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   Pfam; PF14545; DBB; 1.
DR   Pfam; PF18567; TIR_3; 1.
DR   SMART; SM01282; DBB; 1.
DR   SUPFAM; SSF52200; SSF52200; 1.
DR   PROSITE; PS51376; DBB; 1.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Coiled coil; Cytoplasm;
KW   Direct protein sequencing; Membrane; Phosphoprotein; Reference proteome.
FT   CHAIN           1..800
FT                   /note="Phosphoinositide 3-kinase adapter protein 1"
FT                   /id="PRO_0000341275"
FT   DOMAIN          8..145
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   DOMAIN          185..321
FT                   /note="DBB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00707"
FT   REGION          10..144
FT                   /note="Necessary and sufficient to mediate inhibition of
FT                   NF-kappa-B downstream of activated TLRs"
FT                   /evidence="ECO:0000250"
FT   REGION          527..548
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          702..800
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          643..663
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        713..742
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        763..780
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         266
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11163197"
FT   MOD_RES         423
FT                   /note="Phosphotyrosine; by SYK"
FT                   /evidence="ECO:0000305|PubMed:11163197"
FT   MOD_RES         448
FT                   /note="Phosphotyrosine; by SYK"
FT                   /evidence="ECO:0000305|PubMed:11163197"
FT   MOD_RES         463
FT                   /note="Phosphotyrosine; by SYK"
FT                   /evidence="ECO:0000305|PubMed:11163197"
FT   VAR_SEQ         1..168
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11163197"
FT                   /id="VSP_034244"
FT   MUTAGEN         266
FT                   /note="Y->F: Fails to bind PIK3R1 in a BCR-signaling
FT                   dependent manner; when associated with Y-423; Y-448 and Y-
FT                   463."
FT                   /evidence="ECO:0000269|PubMed:11163197"
FT   MUTAGEN         423
FT                   /note="Y->F: Fails to bind PIK3R1 in a BCR-signaling
FT                   dependent manner; when associated with Y-266; Y-448 and Y-
FT                   463."
FT                   /evidence="ECO:0000269|PubMed:11163197"
FT   MUTAGEN         448
FT                   /note="Y->F: Fails to bind PIK3R1 in a BCR-signaling
FT                   dependent manner; when associated with Y-266; Y-423 and Y-
FT                   463."
FT                   /evidence="ECO:0000269|PubMed:11163197"
FT   MUTAGEN         463
FT                   /note="Y->F: Fails to bind PIK3R1 in a BCR-signaling
FT                   dependent manner; when associated with Y-266; Y-423 and Y-
FT                   448."
FT                   /evidence="ECO:0000269|PubMed:11163197"
SQ   SEQUENCE   800 AA;  90156 MW;  E506D0CFE5E558ED CRC64;
     MTASGTHGGY DVLILYASDA AEWCQYLQNL FLSTRHIRKH HIQSYQLEGE SAISDQELDL
     FNRSRSIIIL LSAELVQNFY CPPVLQSLQE ALWPPHKVVK LFCGVTDCDD YLTFFKDWYQ
     WQELTYDDEP DAYLEAVKKA ISEDSGCDSV TDTETEDEKT SVYSCQLAMN EEHESSKSTG
     EHLVVQPDHI RCGVQTTVYI IMKCRLDDKV KTEVEFSPEN SSSVRVLAEL ENEYTISVEA
     PNLTSGTVPL QIYSGDLMVG ETSVTYHTDM EEISSLLANA ANPVQFMCQA FKIVPYSIEA
     LDKLLTESLK KNIPASGLHL FGINQLEEDD MTTNQRDEEL PTLLHFSARY GLKNLTALLL
     TCPGALQAYS VANKYGHYPN TIAEKHGFKD LRQFIDEYVE TADMLKSHIK EELMQGEEDE
     SVYESMAHLS TDLLMKCSLN PGSDEELYES MAGFVPGAPE DLYVEMLQSK PDTPISGDEI
     SLTVKDSMLR KFLEGGSTDA PDSGEGVSQQ YGEDLYYSVE KDTFPQEMAS RPPVPVPRPE
     SSSPQPDNEL YISKVFAQKA QRPENLYVPR GKVRKETIVR PVRDLSQSSI YDPFAGMKTP
     GQRQLITLQE QVKMGILNVD EAVLHFKEWQ LNQKKRSESF RFQQENLKRL RDSITRRQME
     KQKSGKSADL EITVPIRRSH NTLGKPECGI YEYAPRKNIF PPKKELKRGD WKTESTSSTT
     SSASNRSSTR SILSVSSGME GDSEDNEVSE ASRSRSPIPS QAERLPLPLP ERPPRVPPRG
     ASRPVNCEGF YPPPVPPRGR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024